Del. Judge Connolly Says Preambles Are Limiting, Cites Alice in Wonderland, and Invites the Federal Circuit to Weigh In
Genzyme Sues Sarepta for Infringement of Gene Therapy Patents
Genentech and Partners Voluntarily Dismiss IPR Appeals Related to Genentech’s ACTEMRA® (Tocilizumab)
Update on Ophthalmic Anti-VEGF Therapeutics
Update: Post-Trial Briefing in Regeneron v. Mylan Aflibercept BPCIA Case Now Complete
FDA Accepts Xbrane’s sBLA for LUCENTIS® (Ranibizumab) Biosimilar Candidate
Amneal Launches FYLNETRA (pegfilgrastim-pbbk) in the United States
Mabwell Announces Approval of Denosumab Biosimilar MAILISHU in China
FDA Approves EYLEA® (Aflibercept) for Treatment of Retinopathy of Prematurity
Subscribe: Subscribe via RSS
Blogs
Firm/Org